-

Wolters Kluwer supports Brazil with access to trusted medical content on Dengue disease

UpToDate’s trusted content on treatment of Dengue is now available to help with national health emergency

SÃO PAULO--(BUSINESS WIRE)--With the significant growth of Dengue cases in Brazil, Wolters Kluwer Health is providing free, online access to evidence-based information about the disease from its clinical decision support (CDS) resource, UpToDate. Access is available to doctors, even if they are not UpToDate subscribers, as well as to the general community by visiting this link.

According to data from the Brazilian Ministry of Health, by the second week of March 2024, more than 1.3 million probable cases of the disease had been recorded in Brazil, double the volume in the first quarter of 2023. Regarding the incidence coefficient, which represents the risk of new cases occurring, the rate so far is above 660 per 100,000 inhabitants, a value of around 540% higher compared to the same period last year.

Nine states and 201 Brazilian municipalities have declared a health emergency due to the high volume of cases of the disease. Among them are Acre, Amapá, Distrito Federal, Espírito Santo, Goiás, Minas Gerais, Rio de Janeiro, Santa Catarina and São Paulo.

According to Natalia Cabrini, Director of Strategy and Sales, Wolters Kluwer Global Growth Markets, Brazil, the objective of the initiative is to help improve patient care and contribute to reducing the volume of cases in Brazil. She explains: “We are closely monitoring the increase in Dengue cases in Brazil, and our focus is to find ways to contribute to solving this adversity as soon as possible. By providing access to this content covering prevention and early diagnosis to appropriate treatment. We hope to contribute to reducing the impact of the disease on Brazilian public health.”

UpToDate is a market leading clinical decision support (CDS) solution used by two million doctors worldwide. It is an evidence-based clinical decision support solution, authored and reviewed exclusively by doctors recognized in their specialties, and can be accessed from anywhere, whether on a mobile device or online.

UpToDate content is written and reviewed by more than 7,000 authors and section editors, including world-class physicians who choose to contribute to UpToDate to share their expertise and insights with peers in the medical community. In addition, contributors are based all over the world, with over 1,100 based outside of the US.

Content covers over 25 specialties, offering more than 10,000 clinical topics, including Dengue. To access information and recommendations about the virus, simply access the link.

About Wolters Kluwer

Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.

Wolters Kluwer reported 2023 annual revenues of €5.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,400 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Facebook, YouTube and Instagram.

Contacts

Media

André Rebelo
Director, External Communications
Wolters Kluwer Health
+1 (781) 392-2411
andre.rebelo@wolterskluwer.com

Wolters Kluwer Health

AEX:WKL

Release Versions

Contacts

Media

André Rebelo
Director, External Communications
Wolters Kluwer Health
+1 (781) 392-2411
andre.rebelo@wolterskluwer.com

More News From Wolters Kluwer Health

Wolters Kluwer report: unified and proactive care that addresses social drivers of health can help reduce cardiovascular disease

WALTHAM, Mass.--(BUSINESS WIRE)--Wolters Kluwer Health released a new report outlining how healthcare leaders can help drive better patient outcomes for cardiovascular health....

Wolters Kluwer Survey: Over Two-Thirds of U.S. Physicians Have Changed Their Mind, Now Viewing GenAI as Beneficial in Healthcare

WALTHAM, Mass.--(BUSINESS WIRE)--A Wolters Kluwer Health survey finds 68% of U.S. physicians changed views in the last year, now more likely view GenAI as beneficial to healthcare....

Wolters Kluwer strengthens Clinical GenAI market leadership with AI Labs powered by UpToDate

WALTHAM, Mass.--(BUSINESS WIRE)--Wolters Kluwer Health today announced several key milestones for AI Labs, the Clinical Generative AI (GenAI) beta launched in 2023 and powered by UpToDate®, the globally trusted clinical decision support (CDS) solution. AI Labs now has access to the complete set of UpToDate’s evidence-based clinical content and graded recommendations across more than 25 medical specialties. It is the only large language model (LLM) exclusively powered by UpToDate trusted content...
Back to Newsroom